AJP - Heart AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (July 8, 2005). doi:10.1152/ajpheart.00341.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/5/H2251    most recent
00341.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, Y.
Right arrow Articles by Bolli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, Y.
Right arrow Articles by Bolli, R.
Submitted on April 5, 2005
Accepted on July 6, 2005

LATE PRECONDITIONING INDUCED BY NO DONORS, ADENOSINE A1 RECEPTOR AGONISTS, AND {delta}1-OPIOID RECEPTOR AGONISTS IS MEDIATED BY iNOS

Yiru Guo1, Adam B Stein1, Wen-Jian Wu1, Xiaoping Zhu1, Wei Tan1, Qianhong Li1, and Roberto Bolli1*

1 Department of Medicine, Institute of Molecular Cardiology, Louisville, KY, USA

* To whom correspondence should be addressed. E-mail: rbolli{at}louisville.edu.

Although ischemia-induced late preconditioning (PC) is known to be mediated by inducible NO synthase (iNOS), the role of this enzyme in pharmacologically-induced late PC remains unclear. We tested whether targeted disruption of the iNOS gene abrogates late PC elicited by three structurally different NO donors (diethylenetriamine/NO [DETA/NO], nitroglycerin [NTG], and S-nitroso-N-acetylpenicillamine [SNAP]), an adenosine A1 receptor agonist (2-chloro-N(6)-cyclopentyladenosine [CCPA]), and a {delta}1-opioid receptor agonist (TAN-670). Mice were subjected to a 30-min coronary occlusion (O) and 24 h of reperfusion (R). In iNOS-/- mice, infarct size was similar to wild-type (WT) controls, indicating that iNOS does not modulate infarct size in the absence of PC. Pretreatment of WT mice with DETA/NO, NTG, SNAP, TAN-670, or CCPA 24 h prior to coronary occlusion markedly reduced infarct size. In iNOS-/-, however, the late PC effect elicited by DETA/NO, NTG, SNAP, TAN-670, and CCPA was completely abrogated. Furthermore, in WT mice pretreated with TAN-670 or CCPA, the selective iNOS inhibitor 1400W also abolished the delayed PC properties of these drugs. 1400W had no effect in WT mice. These data demonstrate that iNOS plays an obligatory role in NO donor-induced, adenosine A1 receptor agonist-induced, and {delta}1-opioid receptor agonist-induced late PC, underscoring the critical role of this enzyme as a common mediator of cardiac adaptations to stress.




This article has been cited by other articles:


Home page
Card Surg AdultHome page
R. M. Mentzer Jr, M. S. Jahania, and R. D. Lasley
Myocardial Protection
Card. Surg. Adult, January 1, 2008; 3(2008): 443 - 464.
[Full Text]


Home page
Cardiovasc ResHome page
V. W.T. Liu and P. L. Huang
Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice
Cardiovasc Res, January 1, 2008; 77(1): 19 - 29.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Robinet, H. Millart, F. Oszust, W. Hornebeck, and G. Bellon
Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway
FASEB J, July 1, 2007; 21(9): 1968 - 1978.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M.-H. Huang, H.-Q. Wang, W. R. Roeske, Y. Birnbaum, Y. Wu, N.-P. Yang, Y. Lin, Y. Ye, D. J. McAdoo, M. G. Hughes, et al.
Mediating {delta}-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H376 - H384.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Y. Song, C. F. Zwemer, S. E. Whitesall, and L. G. D'Alecy
Acute and conditioned hypoxic tolerance augmented by endothelial nitric oxide synthase inhibition in mice
J Appl Physiol, February 1, 2007; 102(2): 610 - 615.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ye, Y. Lin, S. Atar, M.-H. Huang, J. R. Perez-Polo, B. F. Uretsky, and Y. Birnbaum
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1158 - H1169.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Davidson and M. R. Duchen
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance
Cardiovasc Res, July 1, 2006; 71(1): 10 - 21.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Atar, Y. Ye, Y. Lin, S. Y. Freeberg, S. P. Nishi, S. Rosanio, M.-H. Huang, B. F. Uretsky, J. R. Perez-Polo, and Y. Birnbaum
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1960 - H1968.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.